Invesco Ltd. Heron Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 51,661 shares of HRTX stock, worth $57,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,661

Previous 41,325 25.01%

Holding current value

$57,860

Previous $144,000 29.17%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.73 - $3.67 $17,881 - $37,933	10,336 Added 25.01%	51,661 $102,000
Q2 2024 Aug 13, 2024	SELL	$2.32 - $3.86 $13,509 - $22,476	-5,823 Reduced 12.35%	41,325 $144,000
Q1 2024 May 14, 2024	SELL	$1.71 - $3.06 $17,380 - $31,101	-10,164 Reduced 17.73%	47,148 $130,000
Q4 2023 Feb 12, 2024	SELL	$0.54 - $1.82 $746 - $2,517	-1,383 Reduced 2.36%	57,312 $97,000
Q3 2023 Nov 13, 2023	SELL	$0.97 - $1.8 $8,729 - $16,198	-8,999 Reduced 13.29%	58,695 $60,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $2.88 $15,120 - $39,231	13,622 Added 25.19%	67,694 $78,000
Q1 2023 May 12, 2023	SELL	$1.51 - $3.25 $50,896 - $109,544	-33,706 Reduced 38.4%	54,072 $81,000
Q4 2022 Feb 13, 2023	BUY	$2.25 - $4.67 $9,279 - $19,259	4,124 Added 4.93%	87,778 $219,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $8,549 - $17,259	3,214 Added 4.0%	83,654 $354,000
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $19,566 - $53,509	8,507 Added 11.83%	80,440 $225,000
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $43,387 - $93,147	9,371 Added 14.98%	71,933 $412,000
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $18,328 - $27,657	-2,195 Reduced 3.39%	62,562 $571,000
Q3 2021 Nov 15, 2021	SELL	$10.13 - $15.0 $16.7 Million - $24.7 Million	-1,649,533 Reduced 96.22%	64,757 $692,000
Q2 2021 Aug 17, 2021	SELL	$13.27 - $18.48 $44,414 - $61,852	-3,347 Reduced 0.19%	1,714,290 $26.6 Million
Q1 2021 May 17, 2021	SELL	$14.49 - $20.72 $90,229 - $129,023	-6,227 Reduced 0.36%	1,717,637 $27.8 Million
Q4 2020 Feb 16, 2021	SELL	$14.61 - $22.14 $204,496 - $309,893	-13,997 Reduced 0.81%	1,723,864 $36.5 Million
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $584,761 - $760,147	-42,777 Reduced 2.4%	1,737,861 $25.8 Million
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $16.3 Million - $32.1 Million	1,497,144 Added 528.1%	1,780,638 $26.2 Million
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $218,277 - $524,036	21,337 Added 8.14%	283,494 $3.33 Million
Q4 2019 Feb 14, 2020	SELL	$17.42 - $26.61 $461,943 - $705,643	-26,518 Reduced 9.19%	262,157 $6.16 Million
Q2 2019 Aug 14, 2019	BUY	$16.93 - $26.22 $67 - $104	4 Added 0.0%	288,675 $5.37 Million
Q1 2019 May 15, 2019	SELL	$23.15 - $28.34 $4,954 - $6,064	-214 Reduced 0.07%	288,671 $7.05 Million
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $6.36 Million - $9.25 Million	288,885 New	288,885 $7.49 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account